Adamis pharmaceuticals announces reverse stock split

San diego, may 19, 2023 (globe newswire) -- adamis pharmaceuticals corporation (nasdaq: admp), a commercial-stage biopharmaceutical company, announced today that it will effect a 1-for-70 reverse stock split of its common stock that will become effective on may 22, 2023, at 12:01 a.m., eastern time. adamis' common stock will continue to trade on the nasdaq capital market ("nasdaq") under the symbol “admp” and will begin trading on a split-adjusted basis when the market opens on may 22, 2023.
ADMP Ratings Summary
ADMP Quant Ranking